More Support for Omitting Lymph Node Biopsy in Low-Risk Early Breast Cancer

(MedPage Today) — SAN ANTONIO — Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested.
After 5 years, the regional recurrence-free survival (RRFS) rate was 96.6…